248 related articles for article (PubMed ID: 12023764)
41. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
[TBL] [Abstract][Full Text] [Related]
42. Isolation ratio and T- serotyping of group A streptococci from pediatric upper respiratory tract infections in Turkey.
Topkaya AE; Yildirim T; Arsan S
Anadolu Kardiyol Derg; 2005 Dec; 5(4):302-4. PubMed ID: 16330397
[TBL] [Abstract][Full Text] [Related]
43. Streptococcus pyogenes emm and T types within a decade, 1996-2005: implications for epidemiology and future vaccines.
Nir-Paz R; Korenman Z; Ron M; Michael-Gayego A; Cohen-Poradosu R; Valinsky L; Beall B; Moses AE
Epidemiol Infect; 2010 Jan; 138(1):53-60. PubMed ID: 19480723
[TBL] [Abstract][Full Text] [Related]
44. Membrane cofactor protein (MCP, CD46) binding to clinical isolates of Streptococcus pyogenes: binding to M type 18 strains is independent of Emm or Enn proteins.
Feito MJ; Sánchez A; Oliver MA; Pérez-Caballero D; Rodríguez de Córdoba S; Albertí S; Rojo JM
Mol Immunol; 2007 Jul; 44(14):3571-9. PubMed ID: 17467801
[TBL] [Abstract][Full Text] [Related]
45. Group A streptococcus clones causing repeated epidemics and endemic disease in intravenous drug users.
Léchot P; Schaad HJ; Graf S; Täuber M; Mühlemann K
Scand J Infect Dis; 2001; 33(1):41-6. PubMed ID: 11234976
[TBL] [Abstract][Full Text] [Related]
46. Spread of a highly mucoid Streptococcus pyogenes emm3/ST15 clone.
Tamayo E; Montes M; García-Medina G; García-Arenzana JM; Pérez-Trallero E
BMC Infect Dis; 2010 Aug; 10():233. PubMed ID: 20687911
[TBL] [Abstract][Full Text] [Related]
47. Genome sequence of a serotype M28 strain of group a streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity.
Green NM; Zhang S; Porcella SF; Nagiec MJ; Barbian KD; Beres SB; LeFebvre RB; Musser JM
J Infect Dis; 2005 Sep; 192(5):760-70. PubMed ID: 16088825
[TBL] [Abstract][Full Text] [Related]
48. Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124.
Facklam RF; Martin DR; Lovgren M; Johnson DR; Efstratiou A; Thompson TA; Gowan S; Kriz P; Tyrrell GJ; Kaplan E; Beall B
Clin Infect Dis; 2002 Jan; 34(1):28-38. PubMed ID: 11731942
[TBL] [Abstract][Full Text] [Related]
49. Emm gene polymorphism among temporally clustered group A streptococcal isolates in western Norway.
Mylvaganam H; Bjorvatn B; Hofstad T; Osland A
APMIS; 2000 Apr; 108(4):303-12. PubMed ID: 10843420
[TBL] [Abstract][Full Text] [Related]
50. Molecular epidemiology of group A streptococcus causing scarlet fever in northern Taiwan, 2001-2002.
Chen YY; Huang CT; Yao SM; Chang YC; Shen PW; Chou CY; Li SY
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):289-95. PubMed ID: 17532590
[TBL] [Abstract][Full Text] [Related]
51. Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance.
Li Z; Sakota V; Jackson D; Franklin AR; Beall B;
J Infect Dis; 2003 Nov; 188(10):1587-92. PubMed ID: 14624386
[TBL] [Abstract][Full Text] [Related]
52. Molecular heterogeneity among north Indian isolates of Group A Streptococcus.
Sagar V; Bakshi DK; Nandi S; Ganguly NK; Kumar R; Chakraborti A
Lett Appl Microbiol; 2004; 39(1):84-8. PubMed ID: 15189292
[TBL] [Abstract][Full Text] [Related]
53. Comparison of emm typing and ribotyping with three restriction enzymes to characterize clinical isolates of Streptococcus pyogenes.
Doktor SZ; Beyer JM; Flamm RK; Shortridge VD
J Clin Microbiol; 2005 Jan; 43(1):150-5. PubMed ID: 15634964
[TBL] [Abstract][Full Text] [Related]
54. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.
Michos AG; Bakoula CG; Braoudaki M; Koutouzi FI; Roma ES; Pangalis A; Nikolopoulou G; Kirikou E; Syriopoulou VP
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):295-9. PubMed ID: 19395219
[TBL] [Abstract][Full Text] [Related]
55. Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development.
Smeesters PR; Mardulyn P; Vergison A; Leplae R; Van Melderen L
Vaccine; 2008 Oct; 26(46):5835-42. PubMed ID: 18789365
[TBL] [Abstract][Full Text] [Related]
56. Molecular mechanisms of high level tetracycline-resistance in group A streptococcal isolates, T serotypes 4 and 11.
Matsumoto M; Sakae K; Ohta M; Endo M; Okuno R; Murayama S; Hirasawa K; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Tamaru A; Tomita M; Ogata K; Yasuoka T; Ikebe T; Watanabe H;
Int J Antimicrob Agents; 2005 Feb; 25(2):142-7. PubMed ID: 15664484
[TBL] [Abstract][Full Text] [Related]
57. Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates.
Schmitz FJ; Beyer A; Charpentier E; Normark BH; Schade M; Fluit AC; Hafner D; Novak R
J Infect Dis; 2003 Nov; 188(10):1578-86. PubMed ID: 14624385
[TBL] [Abstract][Full Text] [Related]
58. Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system.
Wahl RU; Lütticken R; Stanzel S; van der Linden M; Reinert RR
Clin Microbiol Infect; 2007 Dec; 13(12):1173-8. PubMed ID: 17850344
[TBL] [Abstract][Full Text] [Related]
59. The virulence factors of group A streptococcus strains isolated from invasive and non-invasive infections in Polish and German centres, 2009-2011.
Strus M; Heczko PB; Golińska E; Tomusiak A; Chmielarczyk A; Dorycka M; van der Linden M; Samet A; Piórkowska A
Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1643-1649. PubMed ID: 28401320
[TBL] [Abstract][Full Text] [Related]
60. Changing epidemiology of acute rheumatic fever in the United States.
Lee GM; Wessels MR
Clin Infect Dis; 2006 Feb; 42(4):448-50. PubMed ID: 16421786
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
